Review: Ocular side effects of anti-rheumatic medications: what a rheumatologist should know-Reference-Cited by-同舟云学术

Review: Ocular side effects of anti-rheumatic medications: what a rheumatologist should know

Published:2010-02-09 Issue:6 Volume:19 Page:675-682
ISSN:0961-2033
Container-title:Lupus
language:en
Short-container-title:Lupus

Author:

Peponis V.¹,Kyttaris VC²,Chalkiadakis SE¹,Bonovas S.³,Sitaras NM³

Affiliation:

1. Athens Eye Hospital, Second Eye Clinic, Athens, Greece

2. Division of Rheumatology, Beth Israel Deaconess Medical Center, , Harvard Medical School, Boston, MA, USA

3. Department of Pharmacology, School of Medicine, University of Athens, Greece

Abstract

Nearly every drug may cause changes to ocular tissues through a variety of mechanisms. Medication overdoses, drug—drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity. The ocular side effects, screening for eye toxicity and treatment guidelines for anti-inflammatory and immunosuppressive drugs commonly used by rheumatologists are reviewed herein.

Publisher

SAGE Publications

Subject

Rheumatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0961203309360539

Reference120 articles.

1. Glucocorticoid receptors: Relations between steroid binding and biological effects

2. The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation

3. Ocular complications of topical, peri-ocular, and systemic corticosteroids

4. Effects of Steroidal and Non-Steroidal Anti-Inflammatory Agents on Corneal Wound Healing

5. Central Serous Chorioretinopathy Associated with Inhaled or Intranasal Corticosteroids

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model via enhancement of the antioxidant defense and minimizing mitochondrial dysfunction;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-09

2. Systemic lupus erythematosus;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Ocular side effects of oncological therapies: Review;Archivos de la Sociedad Española de Oftalmología (English Edition);2023-11

4. Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy;Journal of Inflammation Research;2023-10

5. Efectos secundarios oculares de las terapias oncológicas. Revisión;Archivos de la Sociedad Española de Oftalmología;2023-10